Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis
Challenges in the development of orally bioavailable thrombin active site inhibitors
An enzyme immunoassay for the simultaneous determination of active type-1 plasminogen activator inhibitor (PAI-1), and t-PA/PAI-1 complexes
Influence of heparin thromboprophylaxis on plasma leucocyte elastase levels following lobectomy for lung carcinoma
Ectopic transcript analysis in human antithrombin deficiency
Ethnic variations in the haemostatic system
Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia
Severe hypofibrinogenemia associated with bilateral ischemic necrosis of toes and fingers
Inhibition of extrinsic and intrinsic thrombin generation by a novel synthetic thrombin inhibitor (Ro 46–6240), recombinant hirudin and heparin in human plasma
Acquired von Willebrand disease associated with multiple myeloma; characterization of an inhibitor to von Willebrand factor
Effect of fibrin structure on plasmin-mediated dissolution of plasma clots
Demonstration that venous occlusion fails to release von Willebrand factor multimers
Differential effects of staphylokinase, streptokinase and tissue-type plasminogen activator on the lysis of retracted human plasma clots and fibrinolytic plasma parameters in vitro
British Society for Haemostasis and Thrombosis One day Meeting
Factor VII
Fibrinogen Bβ 448 Polymorphism and Fibrinogen Levels in Acute Stroke
Elevated von Willebrand Factor (vWF)
Detection of a common polymorphism in the angiotensin-1 converting enzyme (ACE) gene promoter
Determinants of the dilute clot lysis time (DCLT) in a healthy general practice-based population—the Harefield Study
Expression of von Willebrand Factor endogenously and after transfection in mammalian cell lines
The significance of anti-interferon antibodies in haemophiliacs receiving interferon α2a for hepatitis C virus infection
Successful Liver Transplant for chronic Hepatitis C in a patient with Mild Factor X Deficiency
Virtual PCR—a novel method to analyse the BglI restriction fragment length polymorphism of the human factor VIII gene
Circulating levels of plasminogen activator inhibitor-1 are elevated in first degree relatives of patients with non-insulin-dependent diabetes
Gender differences in coagulation and fibrinolysis
Insulin Receptor Substrate-1 gene polymorphism and cardiovascular risk in non-insulin dependent diabetes mellitus
Protein S, C4b-binding protein (C4BP) and beta 2-glycoprotein I (β2-GPI) binding interaction
Plasminogen activator inhibitor-1 promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes
Rapid and sequential signalling by endothelial IL-8 and PAF induce capture and then migration of rolling neutrophils
The release of von Willebrand Factor thrombomodulin and p-selectin from cultured endothelial cells induced by cyclosporin
Thrombopoietin potentiates agonist activation of platelets in association with JAK2 phosphorylation
Collagen, wheat germ agglutinin and cross-linking of the platelet low affinity Fc receptor induce activation of the tyrosine kinase syk
Calibrated plasmas improve interlaboratory agreement of INR estimation
The importance of confirming APC resistance by genetic analysis
Low APCR and thrombotic risk without factor V Leiden
Activated Protein C resistance in patients with unstable angina
Influence of Helicobacter Pylori Status on Circulating Levels of Coagulation Factors
Circulating markers of coagulation in subtypes of ischaemic stroke and primary intracerebral haemorrhage
Plasminogen activator inhibitor activity in patients with lupus anticoagulant
Plasminogen activator inhibitor-1 promoter polymorphism and activity in relation to the extent of coronary artery disease
The coagulation/fibrinolysis balance in thrombotic and non thrombotic patients with idiopathic antiphospholipid antibodies
Inhibition of proteolysis by leucocytes from patients with septicaemia
Leucocytes from patients with septicaemia enhance release of plasminogen activator inhibitor-1 (PAI-l) by endothelial cells
A modified 14C-Serotonin platelet release method for the diagnosis of Heparin-Induced Thrombocytopenia (HIT)
A low molecular weight heparin, nadroparin (FRAXI-PARINE), inhibits thrombin-induced platelet shape change
A copper-mediated mechanism in the anti-platelet action of S-nitrosothiols